NeuroVasc Technologies Announces First Patient Treated in Clinical Trial to Evaluate Its Novel Stent-Retriever

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Japan ,United States ,United Kingdom ,China ,Florida ,California ,Canada ,Toronto ,Ontario ,France ,Irvine ,Raul Nogueira ,Nima Amin Aghaebrahim ,Vitor Mendes Pereira ,Ricardo Hanel ,Michael Losordo ,Stroke Institute ,University Of Pittsburgh Medical Center ,World Health Organization ,Baptist Stroke Cerebrovascular Center ,Vastrax Inc ,University Of Toronto ,Neurovasc Technologies Inc ,Medtronic ,Vasc Technologies ,Neurovasc Envi ,Controlled Trial ,Endovascular Treatment ,Principal Investor ,Pittsburgh Medical Center ,Modified Rankin Scale ,Control Devices ,Baptist Stroke ,Cerebrovascular Center ,Ischemic Stroke ,Neurovasc Technologies ,Business Wire ,Technology ,Health ,Business ,Stroke ,Clinical Trials ,